EGFR, HER2, and HER3 Expression in Laryngeal Primary Tumors and Corresponding Metastases
2008 · Annals of Surgical Oncology · 59 citations
https://doi.org/10.1245/s10434-007-9771-3
Y
Yongjie Shui
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
60
Papers
980
Citations
17
h-index
26
i10-index
Yongjie Shui is an academic researcher from Ministry of Education of the People's Republic of China. The author has contributed to research in topics: Hepatocellular Carcinoma Treatment and Prognosis & Cholangiocarcinoma and Gallbladder Cancer Studies & Gallbladder and Bile Duct Disorders. The author has an h-index of 17, co-authored 51 publications.
ORCID: 0000-0002-5786-7321Papers by this author
worksEpidermal growth factor receptor and human epidermal growth receptor 2 expression in parotid mucoepidermoid carcinoma: Possible implications for targeted therapy
2008 · Oncology Reports · 38 citations
https://doi.org/10.3892/or.19.2.435
EGFR and HER2 expression in primary cervical cancers and corresponding lymph node metastases: Implications for targeted radiotherapy
2008 · BMC Cancer · 37 citations
https://doi.org/10.1186/1471-2407-8-232
Postoperative recurrent patterns of gallbladder cancer: possible implications for adjuvant therapy
2022 · Radiation Oncology · 15 citations
https://doi.org/10.1186/s13014-022-02091-6
Adjuvant therapy with gemcitabine and stereotactic body radiation therapy versus gemcitabine alone for resected stage II pancreatic cancer: a prospective, randomized, open-label, single center trial
2022 · BMC Cancer · 8 citations
https://doi.org/10.1186/s12885-022-09974-7
MOESM1 of Glioma SOX2 expression decreased after adjuvant therapy
2019 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.10297094
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat